Biotechnology
Breaking News
Market News
Technology
The Market Buzz
Breaking News: Algernon Appoints U.S. Company for cGMP Manufacturing of NP-120 (Ifenprodil) for COVID-19 Clinical Trials
Algernon Pharmaceuticals Inc. (CSE: AGN) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company announces that it has awarded the contract to manufacture the active pharmaceutical...
